The Incredible Dividend Map... Where Stocks Yield 26% a Year!

From Investing Daily | Ad

What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.

Get in on the action here.

GLYC Insider Trading (GlycoMimetics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.00%

Insider Buying (Last 12 Months): $82,000.00

Insider Selling (Last 12 Months): $6,696.96

GlycoMimetics Insider Trading History Chart

GlycoMimetics Share Price & Price History

^$0.89

▲ +0.09 (11.24%)

As of 08/10/2022 01:00 AM ET

Days: 30 | 90 | 365

A One Stop Shop for Everything Futures Trading

From RJO Futures | Ad

Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!

Download your FREE Technical Analysis Trading Guide Today.

GlycoMimetics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/9/2022	Brian M Hahn	CFO	Sell	2,917	$1.09	$3,179.53
3/9/2022	John L Magnani	SVP	Sell	3,227	$1.09	$3,517.43
11/16/2021	Patricia S. Andrews	Director	Buy	40,000	$2.05	$82,000.00
11/4/2020	Bvf Partners L P/Il	Major Shareholder	Buy	1,266,737	$2.60	$3,293,516.20
10/30/2020	Bvf Partners L P/Il	Major Shareholder	Buy	932,612	$2.75	$2,564,683.00
3/9/2020	Daniel M Junius	Director	Buy	20,000	$3.40	$68,000.00	38,000
9/5/2019	Bvf Partners L P/Il	Major Shareholder	Buy	1,668,746	$3.18	$5,306,612.28
8/13/2019	Daniel M Junius	Director	Buy	10,000	$3.18	$31,800.00	18,000

Sell every Stock except ONE

From Legacy Research | Ad

Markets are down...But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE.

He lives financially free trading this One Stock Once per month...

Ticker Revealed.

SEC Filings (Institutional Ownership Changes) for GlycoMimetics (NASDAQ:GLYC)

56.64% of GlycoMimetics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

GlycoMimetics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/13/2022	Renaissance Technologies LLC	470,600	$0.54M	0.0%	-21.7%	0.898%
5/13/2022	Federated Hermes Inc.	217,116	$0.25M	0.0%	-37.2%	0.414%
5/13/2022	Vanguard Group Inc.	1,814,963	$2.07M	0.0%	-18.9%	3.464%
5/13/2022	Dimensional Fund Advisors LP	271,129	$0.31M	0.0%	-52.0%	0.518%
5/12/2022	Acadian Asset Management LLC	1,990,087	$2.27M	0.0%	+2.0%	3.798%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	89,926	$0.10M	0.0%	-24.7%	0.172%
2/14/2022	Eversept Partners LP	100,000	$0.14M	0.0%	N/A	0.193%
2/14/2022	GSA Capital Partners LLP	146,078	$0.21M	0.0%	N/A	0.282%
2/10/2022	Acadian Asset Management LLC	1,951,086	$2.81M	0.0%	+3.4%	3.771%
11/16/2021	Two Sigma Advisers LP	621,000	$1.36M	0.0%	-12.4%	1.200%
11/16/2021	Two Sigma Investments LP	498,530	$1.09M	0.0%	+121.0%	0.964%
11/15/2021	Dimensional Fund Advisors LP	904,628	$1.98M	0.0%	-23.3%	1.748%
11/15/2021	Franklin Resources Inc.	160,700	$0.35M	0.0%	N/A	0.311%
11/12/2021	Renaissance Technologies LLC	596,100	$1.31M	0.0%	-21.3%	1.152%
11/12/2021	Connor Clark & Lunn Investment Management Ltd.	112,298	$0.25M	0.0%	+5.5%	0.217%
11/9/2021	BlackRock Inc.	875,151	$1.92M	0.0%	-1.2%	1.691%
8/17/2021	Millennium Management LLC	686,577	$1.59M	0.0%	+1,284.5%	1.332%
8/17/2021	Bridgeway Capital Management LLC	215,700	$0.50M	0.0%	+26.4%	0.419%
8/16/2021	Squarepoint Ops LLC	16,216	$38K	0.0%	N/A	0.031%
8/16/2021	AQR Capital Management LLC	97,590	$0.23M	0.0%	-54.0%	0.189%
8/16/2021	LMR Partners LLP	22,889	$53K	0.0%	N/A	0.044%
8/16/2021	Charles Schwab Investment Management Inc.	11,422	$27K	0.0%	-87.0%	0.022%
8/16/2021	State Street Corp	144,265	$0.34M	0.0%	-77.9%	0.280%
8/16/2021	Tibra Equities Europe Ltd	136,100	$0.32M	0.1%	N/A	0.264%
8/16/2021	Goldman Sachs Group Inc.	123,407	$0.29M	0.0%	+253.3%	0.239%
8/13/2021	Renaissance Technologies LLC	757,693	$1.76M	0.0%	+20.9%	1.470%
8/13/2021	Northern Trust Corp	108,713	$0.25M	0.0%	-71.8%	0.211%
8/13/2021	Intellectus Partners LLC	123,000	$0.29M	0.1%	+51.9%	0.239%
8/13/2021	Jump Financial LLC	18,000	$42K	0.0%	N/A	0.035%
8/13/2021	QS Investors LLC	160,700	$0.37M	0.0%	+58.3%	0.312%
8/13/2021	Qube Research & Technologies Ltd	14,488	$34K	0.0%	N/A	0.028%
8/13/2021	Geode Capital Management LLC	352,740	$0.82M	0.0%	-51.0%	0.684%
8/13/2021	Vanguard Group Inc.	2,270,457	$5.27M	0.0%	-14.6%	4.405%
8/12/2021	XTX Topco Ltd	58,992	$0.14M	0.0%	N/A	0.114%
8/12/2021	Dimensional Fund Advisors LP	1,178,938	$2.74M	0.0%	-2.9%	2.287%
8/12/2021	Advisory Services Network LLC	35,800	$83K	0.0%	N/A	0.069%
8/12/2021	JPMorgan Chase & Co.	263,914	$0.61M	0.0%	+4.6%	0.512%
8/12/2021	Ergoteles LLC	160,900	$0.37M	0.0%	N/A	0.312%
8/12/2021	Connor Clark & Lunn Investment Management Ltd.	106,442	$0.25M	0.0%	-16.8%	0.207%
8/11/2021	Bank of New York Mellon Corp	26,664	$62K	0.0%	-80.4%	0.052%
8/11/2021	BlackRock Inc.	886,148	$2.06M	0.0%	-68.6%	1.719%
8/11/2021	Susquehanna Fundamental Investments LLC	144,717	$0.34M	0.0%	+268.2%	0.281%
5/18/2021	Millennium Management LLC	49,591	$0.15M	0.0%	-77.7%	0.096%
5/18/2021	D. E. Shaw & Co. Inc.	515,898	$1.55M	0.0%	-10.7%	1.001%
5/18/2021	Cubist Systematic Strategies LLC	26,900	$81K	0.0%	+62.4%	0.052%
5/18/2021	Man Group plc	27,900	$84K	0.0%	-51.1%	0.054%
5/18/2021	Jane Street Group LLC	11,543	$35K	0.0%	N/A	0.022%
5/17/2021	PDT Partners LLC	82,300	$0.25M	0.0%	+59.5%	0.160%
5/17/2021	AQR Capital Management LLC	212,088	$0.64M	0.0%	N/A	0.412%
5/17/2021	Intellectus Partners LLC	81,000	$0.24M	0.1%	+710.0%	0.157%
5/17/2021	Nuveen Asset Management LLC	1,059,121	$3.19M	0.0%	+171.2%	2.055%
5/17/2021	Goldman Sachs Group Inc.	34,930	$0.11M	0.0%	-30.8%	0.068%
5/14/2021	Dimensional Fund Advisors LP	1,214,587	$3.66M	0.0%	+0.5%	2.357%
5/13/2021	QS Investors LLC	101,500	$0.31M	0.0%	N/A	0.197%
5/13/2021	ClariVest Asset Management LLC	168,800	$0.51M	0.0%	+29.8%	0.328%
5/13/2021	Barclays PLC	31,020	$93K	0.0%	+158.4%	0.060%
5/13/2021	Renaissance Technologies LLC	626,500	$1.89M	0.0%	-12.5%	1.216%
5/13/2021	Bank of New York Mellon Corp	136,337	$0.41M	0.0%	+3.1%	0.265%
5/13/2021	Federated Hermes Inc.	342,631	$1.03M	0.0%	-17.0%	0.665%
5/12/2021	Northern Trust Corp	385,772	$1.16M	0.0%	-10.8%	0.749%
5/12/2021	Geode Capital Management LLC	720,179	$2.17M	0.0%	+7.0%	1.397%
5/12/2021	JPMorgan Chase & Co.	252,200	$0.76M	0.0%	+24.4%	0.489%
5/12/2021	Panagora Asset Management Inc.	65,061	$0.20M	0.0%	-38.7%	0.126%
5/12/2021	UBS Group AG	27,454	$83K	0.0%	-53.5%	0.053%
5/11/2021	Acadian Asset Management LLC	1,645,295	$4.95M	0.0%	+103.2%	3.192%
5/7/2021	BlackRock Inc.	2,823,587	$8.50M	0.0%	+7.9%	5.479%
5/7/2021	BNP Paribas Arbitrage SA	15,071	$45K	0.0%	+113.6%	0.029%
5/4/2021	Commonwealth Equity Services LLC	10,000	$30K	0.0%	N/A	0.019%
5/4/2021	Ieq Capital LLC	38,363	$0.12M	0.0%	N/A	0.074%
3/8/2021	Dimensional Fund Advisors LP	1,208,120	$4.54M	0.0%	+0.9%	2.346%
2/25/2021	Dimensional Fund Advisors LP	1,208,120	$4.54M	0.0%	+0.9%	2.526%
2/24/2021	Virtu Financial LLC	12,826	$48K	0.0%	N/A	0.027%
2/19/2021	JPMorgan Chase & Co.	202,776	$0.76M	0.0%	+171.9%	0.424%
2/18/2021	Intellectus Partners LLC	10,000	$38K	0.0%	N/A	0.021%
2/16/2021	Squarepoint Ops LLC	39,862	$0.15M	0.0%	+25.5%	0.083%
2/16/2021	LMR Partners LLP	10,527	$40K	0.0%	-30.0%	0.022%
2/16/2021	Nuveen Asset Management LLC	390,594	$1.47M	0.0%	+14.1%	0.817%
2/16/2021	Caption Management LLC	27,508	$0.10M	0.0%	-81.5%	0.058%
2/16/2021	ExodusPoint Capital Management LP	55,095	$0.21M	0.0%	N/A	0.115%
2/12/2021	Caas Capital Management LP	500,225	$1.88M	0.0%	N/A	1.046%
2/12/2021	Federated Hermes Inc.	412,998	$1.55M	0.0%	-17.4%	0.863%
2/12/2021	The Manufacturers Life Insurance Company	25,858	$97K	0.0%	+15.5%	0.054%
2/12/2021	Healthcare of Ontario Pension Plan Trust Fund	899,500	$3.38M	0.0%	N/A	1.881%
2/11/2021	JBF Capital Inc.	56,400	$56K	0.0%	+276.0%	0.118%
2/11/2021	Northern Trust Corp	432,437	$1.63M	0.0%	-3.7%	0.904%
2/11/2021	HITE Hedge Asset Management LLC	78,621	$0.30M	0.1%	N/A	0.164%
2/11/2021	Barclays PLC	12,004	$45K	0.0%	-40.5%	0.025%
2/10/2021	Rhumbline Advisers	60,730	$0.23M	0.0%	+15.0%	0.127%
2/10/2021	Renaissance Technologies LLC	716,300	$2.69M	0.0%	+181.2%	1.498%
2/10/2021	Panagora Asset Management Inc.	106,163	$0.40M	0.0%	-40.6%	0.222%
2/9/2021	Wells Fargo & Company MN	105,814	$0.40M	0.0%	+108.5%	0.221%
2/9/2021	Bank of New York Mellon Corp	132,232	$0.50M	0.0%	+2.3%	0.276%
2/8/2021	Russell Investments Group Ltd.	90,190	$0.34M	0.0%	+1,389.5%	0.189%
2/5/2021	BlackRock Inc.	2,616,477	$9.84M	0.0%	-10.9%	5.470%
2/5/2021	SG Americas Securities LLC	14,664	$55K	0.0%	N/A	0.031%
2/4/2021	Prentiss Smith & Co. Inc.	14,000	$53K	0.0%	N/A	0.029%
11/16/2020	Camber Capital Management LP	2,500,000	$7.68M	0.4%	-16.7%	5.227%
11/16/2020	Squarepoint Ops LLC	31,773	$98K	0.0%	-36.0%	0.066%
11/13/2020	Morgan Stanley	305,288	$0.94M	0.0%	-53.9%	0.638%
11/12/2020	JBF Capital Inc.	15,000	$46K	0.0%	N/A	0.031%

Data available starting January 2016

GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as in phase 3 trial to treat relapsed/refractory AML. In addition, the company is developing GMI-1359, which targets e-selectin and a chemokine receptor for the treatment of cancers that affect the bone and bone marrow, including solid tumors. It also develops various other programs, including GMI-1687, an antagonist of E-selectin to treat vaso-occlusive crisis; and galectin-3 antagonists, a carbohydrate-binding protein. The company has a cooperative research and development agreement with the National Cancer Institute; and a collaboration and license agreement with Apollomics (Hong Kong) Limited for the development and commercialization of uproleselan and GMI-1687. GlycoMimetics, Inc. was incorporated in 2003 and is headquartered in Rockville, Maryland.

Today's Range

Now: $0.89

$0.81

$0.90

50 Day Range

MA: $0.66

$0.54

$0.90

52 Week Range

Now: $0.89

$0.51

$2.50

Volume

219,616 shs

Average Volume

187,855 shs

Market Capitalization

$46.68 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.85

Who are the company insiders with the largest holdings of GlycoMimetics?: GlycoMimetics' top insider shareholders include:
Brian M Hahn (CFO)
Bvf Partners L P/Il (Major Shareholder)
John L Magnani (SVP)
Patricia S Andrews (Director)
Learn More about top insider investors at GlycoMimetics.

The Safest Option in Trades!

From Tradewins | Ad

If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

Click here now!